Top Midday Decliners

MT Newswires Live

Mar 19

GSI Technology (GSIT) said Wednesday its board has completed s strategic alternatives review and decided to continue operating as a standalone company.

Shares were down 25% intraday, with trading volume of over 2.8 million shares versus a daily average of roughly 1.6 million.

Cibus (CBUS) reported a wider-than-expected Q4 net loss late Tuesday and a decrease in quarterly revenue.

Shares slid nearly 21% as intraday trading volume jumped to over 750,000 from a daily average of about 435,000.

Protalix BioTherapeutics (PLX) swung to a full-year EPS loss and reported a decrease in revenue.

Shares fell about 19%, with intraday trading volume of over 2.9 million shares versus a daily average of roughly 1.2 million.

Price: 6.35, Change: -2.14, Percent Change: -25.22

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/2620266667"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2620266667\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2620266667?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-19 02:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2620266667","market":"hk","top_or_hot":-1,"title":"Top Midday Decliners","media":"MT Newswires Live","content":"<html><body><p> GSI Technology (GSIT) said Wednesday its board has completed s strategic alternatives review and decided to continue operating as a standalone company.</p><p>Shares were down 25% intraday, with trading volume of over 2.8 million shares versus a daily average of roughly 1.6 million.</p><p>Cibus (CBUS) reported a wider-than-expected Q4 net loss late Tuesday and a decrease in quarterly revenue.</p><p>Shares slid nearly 21% as intraday trading volume jumped to over 750,000 from a daily average of about 435,000.</p><p>Protalix BioTherapeutics (PLX) swung to a full-year EPS loss and reported a decrease in revenue.</p><p>Shares fell about 19%, with intraday trading volume of over 2.9 million shares versus a daily average of roughly 1.2 million.</p><p>Price: 6.35, Change: -2.14, Percent Change: -25.22</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Top Midday Decliners</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTop Midday Decliners\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-03-19 02:03</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> GSI Technology (GSIT) said Wednesday its board has completed s strategic alternatives review and decided to continue operating as a standalone company.</p><p>Shares were down 25% intraday, with trading volume of over 2.8 million shares versus a daily average of roughly 1.6 million.</p><p>Cibus (CBUS) reported a wider-than-expected Q4 net loss late Tuesday and a decrease in quarterly revenue.</p><p>Shares slid nearly 21% as intraday trading volume jumped to over 750,000 from a daily average of about 435,000.</p><p>Protalix BioTherapeutics (PLX) swung to a full-year EPS loss and reported a decrease in revenue.</p><p>Shares fell about 19%, with intraday trading volume of over 2.9 million shares versus a daily average of roughly 1.2 million.</p><p>Price: 6.35, Change: -2.14, Percent Change: -25.22</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CBUS","symbol_name":"Cibus Inc","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2620266667","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2620266667","pubTimestamp":1773856986,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"GSI Technology  said Wednesday its board has completed s strategic alternatives review and decided to continue operating as a standalone company.Shares were down 25% intraday, with trading volume of over 2.8 million shares versus a daily average of roughly 1.6 million.Cibus  reported a wider-than-expected Q4 net loss late Tuesday and a decrease in quarterly revenue.Shares slid nearly 21% as intraday trading volume jumped to over 750,000 from a daily average of about 435,000.Protalix BioTherapeutics  swung to a full-year EPS loss and reported a decrease in revenue.Shares fell about 19%, with intraday trading volume of over 2.9 million shares versus a daily average of roughly 1.2 million.Price: 6.35, Change: -2.14, Percent Change: -25.22","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"CBUS":"Cibus Inc","BK4139":"生物科技","BK4141":"半导体产品","PLX":"Protalix BioTherapeutics Inc","GSIT":"Gsi Technology"},"translate_title":"午盘跌幅最大的股票","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CBUS":1,"PLX":1,"GSIT":1},"content_text":"GSI Technology (GSIT) said Wednesday its board has completed s strategic alternatives review and decided to continue operating as a standalone company.Shares were down 25% intraday, with trading volume of over 2.8 million shares versus a daily average of roughly 1.6 million.Cibus (CBUS) reported a wider-than-expected Q4 net loss late Tuesday and a decrease in quarterly revenue.Shares slid nearly 21% as intraday trading volume jumped to over 750,000 from a daily average of about 435,000.Protalix BioTherapeutics (PLX) swung to a full-year EPS loss and reported a decrease in revenue.Shares fell about 19%, with intraday trading volume of over 2.9 million shares versus a daily average of roughly 1.2 million.Price: 6.35, Change: -2.14, Percent Change: -25.22","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}